The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
The global macroeconomic burden of Alzheimer's disease and other dementias: estimates and projections for 152 countries or territories
Open accessAbstract
BACKGROUND: Alzheimer's disease and other dementias (ADODs) severely threaten the wellbeing of older people, their families, and communities, especially with projected exponential growth. Understanding the macroeconomic implications of ADODs for policy making is essential but under-researched. METHODS: We used a health-augmented macroeconomic model to calculate the macroeconomic burden of ADODs for 152 countries or territories, accounting for: the effect on labour supply of reduced working hours of informal caregivers; the effect on labour supply of ADODs-related mortality and morbidity; age-sex-specific differences in education, work experience, labour market participations, and informal caregivers; and treatment and formal care costs diverting from savings and investments. FINDINGS: ADODs will cost the world economy 14 513 billion international dollars (INT$, measured in the base year 2020; 95% uncertainty interval [UI] 12 106-17 778) from 2020 to 2050, equivalent to 0·421% (95% UI 0·351-0·515) of annual global GDP. Japan incurs the largest annual GDP loss at 1·463% (1·225-1·790). China (INT$2961 billion [2507-3564]), the USA (INT$2331 billion [1989-2829]), and Japan (INT$1758 billion [1471-2150]) face the largest absolute economic burdens. The economic burden of informal care ranges from 60·97% in high-income countries to 85·45% in lower-middle-income countries, and treatment and formal care costs range from 10·50% in lower-middle-income countries to 30·80% in high-income countries. INTERPRETATION: The macroeconomic burden of ADODs is substantial and unequally distributed across countries and regions. Global efforts to reduce the burden, especially with regard to informal care, are urgently needed. FUNDING: National Institute on Aging, National Institutes of Health; Chinese Academy of Engineering; Chinese Academy of Medical Sciences; Bill & Melinda Gates Foundation; Davos Alzheimer's Collaborative through Data for Decisions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Dementia prevention, intervention, and care: 2020 report of the Lancet Commission
Livingston, G., Huntley, J., Sommerlad, A., Ames, D., Ballard, C., Banerjee, S., Brayne, C., Burns, A., Cohen-Mansfield, J., Cooper, C., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30367-6 · Cited by 10,430
RetractedNichols, E., Steinmetz, J. D., Vollset, S. E., Fukutaki, K., Chalek, J., Abd-Allah, F., Abdoli, A., Abualhasan, A., Abu-Gharbieh, E., Akram, T. T., et al. (2022) · The Lancet Public Health · doi:10.1016/s2468-2667(21)00249-8 · Cited by 5,575
(2015) · HAL · Cited by 2,238
Gender inequality and restrictive gender norms: Framing the challenges to health
Heise, L., Greene, M. E., Opper, N., Stavropoulou, M., Harper, C., Nascimento, M., Zewdie, D., Darmstadt, G. L., Greene, M. E., Hawkes, S., et al. (2019) · The Lancet · doi:10.1016/s0140-6736(19)30652-x · Cited by 1,163
Chen, S., Cao, Z., Prettner, K., Kuhn, M., Yang, J., Jiao, L., Wang, Z., Li, W., Geldsetzer, P., Bärnighausen, T., et al. (2023) · JAMA Oncology · doi:10.1001/jamaoncol.2022.7826 · Cited by 890
Self-citationThe cost of Alzheimer's disease in China and re‐estimation of costs worldwide
Jia, J., Wei, C., Chen, S., Li, F., Tang, Y., Qin, W., Zhao, L., Jin, H., Xu, H., Wang, F., et al. (2018) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2017.12.006 · Cited by 752
Self-citationThe global macroeconomic burden of road injuries: estimates and projections for 166 countries
Chen, S., Kuhn, M., Prettner, K., & Bloom, D. E. (2019) · The Lancet Planetary Health · doi:10.1016/s2542-5196(19)30170-6 · Cited by 653
Self-citationThe worldwide costs of dementia in 2019
Wimo, A., Seeher, K., Cataldi, R., Cyhlarova, E., Dielemann, J. L., Frisell, O., Guerchet, M., Jönsson, L., Malaha, A. K., Nichols, E., et al. (2023) · Alzheimer's & Dementia · doi:10.1002/alz.12901 · Cited by 559
Chen, S., Kuhn, M., Prettner, K., Yu, F., Yang, T., Bärnighausen, T., Bloom, D. E., & Wang, C. (2023) · The Lancet Global Health · doi:10.1016/s2214-109x(23)00217-6 · Cited by 487
Self-citationDrug development in Alzheimer’s disease: the path to 2025
Cummings, J., Aisen, P. S., DuBois, B., Frölich, L., Jack, C. R., Jones, R. W., Morris, J. C., Raskin, J., Dowsett, S. A., & Scheltens, P. (2016) · Alzheimer's Research & Therapy · doi:10.1186/s13195-016-0207-9 · Cited by 459
Cited by
Global health 2050: the path to halving premature death by mid-century
Jamison, D. T., Summers, L. H., Chang, A. Y., Karlsson, O., Mao, W., Norheim, O. F., Ogbuoji, O., Schäferhoff, M., Watkins, D., Adeyi, O., et al. (2024) · The Lancet · doi:10.1016/s0140-6736(24)01439-9 · Cited by 125
Self-citationLiu, W., Deng, W., Gong, X., Ou, J., Yu, S., & Chen, S. (2025) · BMC Public Health · doi:10.1186/s12889-025-22378-z · Cited by 104
“At the same time, the treatment and care of elderly individuals with dementia often place a heavier financial burden on their families [29].”
Self-citationThe global macroeconomic burden of diabetes mellitus
Chen, S., Cao, Z., Chen, W., Zhao, J., Jiao, L., Klaus Prettner, A., Kühn, M., Pan, A., Bärnighausen, T., & Bloom, D. E. (2025) · Nature Medicine · doi:10.1038/s41591-025-04027-5 · Cited by 78
“A substantial portion of this burden comes from informal caregiving, with lower-middle-income countries having 85.45% of the total burden attributed to caregiving 22 .”
InfluentialSelf-citationAlzheimer’s disease pathogenesis: standing at the crossroad of lipid metabolism and immune response
Wang, Z., Zhang, L., & Qin, C. (2025) · Molecular Neurodegeneration · doi:10.1186/s13024-025-00857-6 · Cited by 63
“Currently, patients with AD often require long-term treatment and care, imposing significant economic and psychological burdens on both families and society [3, 4].”
Wang, R. (2025) · Neuroepidemiology · doi:10.1159/000543578 · Cited by 60
“Chen et al. [13] used a health-augmented macroeconomic model and predicted that AD and other dementias would cost the world economy 14,513 (95% uncertainty interval [UI]: 12,106 – 17,778) billion international dollars from 2020 to 2050, equivalent to 0.421% (95% UI: 0.351 – 0.515) of annual global…”
Influential
Metadata
- Authors
- Chen, S., Cao, Z., Nandi, A., Counts, N., Jiao, L., Prettner, K., Kuhn, M., Seligman, B., Tortorice, D., Vigo, D., Wang, C., & Bloom, D. E.
- Affiliations
- Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
- Tsinghua University (CN)
- Population Council (US)
- Albert Einstein College of Medicine (US)
- Columbia University (US)
- University of California, Los Angeles (US)
- College of the Holy Cross (US)
- University of British Columbia (CA)
- Harvard University (US)
- Corresponding author
- Chen, Simiao
- Wang, Chen
- ORCID
- Venue
- The Lancet Global Health
- Publisher
- Elsevier BV
- Published
- 2024-09
- Volume
- 12
- Issue
- 9
- Pages
- e1534-e1543
- ISSN
- 2214-109X (ISSN-L)
- OpenAlex
- W4401560172
- Cited by
- 294
- References
- 22
- Citations by year
- 2026: 172 · 2025: 119 · 2024: 3
- FWCI
- 86.42
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- creativecommons.org/licenses/by/4.0/ (vor)
- Locations
- The Lancet Global Health (publishedVersion, cc-by)
- PubMed (publishedVersion)
- IIASA PURE (International Institute of Applied Systems Analysis) (acceptedVersion)
- WU Research (submittedVersion, cc-by)
- Funders
- Bill and Melinda Gates Foundation
- Chinese Academy of Medical Sciences (2024-CFT-QT-034)
- Peking Union Medical College
- Chinese Academy of Engineering
- National Institutes of Health
- HORIZON EUROPE Framework Programme (101086139, HORIZON-MSCA-2021-SE-01)
- National Institute on Aging (R01AG048037, P30AG024409)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Global Health Care Issues
- Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Health Systems, Economic Evaluations, Quality of Life
- Keywords
- Alzheimer's disease, dementia, informal caregivers, labor supply
- MeSH terms
- Aged, Alzheimer Disease, Dementia, Female, Humans, Male, Global Health, Caregivers, Cost of Illness
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The global macroeconomic burden of Alzheimer's disease and other dementias: estimates and projections for 152 countries or territories. https://app.cochat.ai/papers/10.1016/s2214-109x(24)00264-x
- The paper
- Chen, S., Cao, Z., Nandi, A., Counts, N., Jiao, L., Prettner, K., Kuhn, M., Seligman, B., Tortorice, D., Vigo, D., Wang, C., & Bloom, D. E. (2024). The global macroeconomic burden of Alzheimer's disease and other dementias: estimates and projections for 152 countries or territories. The Lancet Global Health. https://doi.org/10.1016/s2214-109x(24)00264-x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.